CIK 0001010086
- Accelerated filer
SIGA TECHNOLOGIES INC
Sign in to watch- Ticker
- SIGA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133864870
- Phone
- +1 212-672-9100
- Business address
- 31 EAST 62ND STREET, NEW YORK, NY, 10065
- Former names
- SIGA PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −6,250 | 43,750 | ||
| 2015-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −6,250 | 68,750 | ||
| 2015-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −5,000 | $1.63 | $8K | 74,124 |
| 2015-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −2,500 | $1.61 | $4K | 71,624 |
| 2015-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −24,500 | $1.60 | $39K | 47,124 |
| 2015-06-04 | Luckshire Daniel J Executive VP & CFO | Exercise or conversion | +2,917 | 36,436 | ||
| 2015-06-04 | Luckshire Daniel J Executive VP & CFO | Exercise or conversion | +8,333 | 44,769 | ||
| 2015-06-04 | Luckshire Daniel J Executive VP & CFO | Exercise or conversion | +8,333 | 53,102 | ||
| 2015-06-04 | Luckshire Daniel J Executive VP & CFO | Exercise or conversion · Restricted Stock Units | −2,917 | 8,751 | ||
| 2015-06-04 | Luckshire Daniel J Executive VP & CFO | Exercise or conversion · Restricted Stock Units | −8,333 | 58,334 | ||
| 2015-06-04 | Luckshire Daniel J Executive VP & CFO | Exercise or conversion · Restricted Stock Units | −8,333 | 91,667 | ||
| 2015-06-04 | Haynes William J II Executive VP & General Counsel | Exercise or conversion | +6,250 | 20,187 | ||
| 2015-06-04 | Haynes William J II Executive VP & General Counsel | Exercise or conversion | +6,250 | 26,437 | ||
| 2015-06-04 | Haynes William J II Executive VP & General Counsel | Exercise or conversion · Restricted Stock Units | −6,250 | 43,750 | ||
| 2015-06-04 | Haynes William J II Executive VP & General Counsel | Exercise or conversion · Restricted Stock Units | −6,250 | 68,750 | ||
| 2015-06-04 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −5,000 | $1.61 | $8K | 79,124 |
| 2015-06-04 | ROSE ERIC A MD Chief Executive Officer | Sale | −12,400 | $1.64 | $20K | 447,897 |
| 2015-06-03 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −3,000 | $1.78 | $5K | 84,124 |
| 2015-06-03 | ROSE ERIC A MD Chief Executive Officer | Sale | −12,500 | $1.69 | $21K | 460,297 |
| 2015-06-02 | ROSE ERIC A MD Chief Executive Officer | Sale | −100 | $1.80 | $180 | 472,797 |
Page 29 of 38 · 760 trades